Johnson & Johnson to Participate in the Credit Suisse 31^st Annual Healthcare Conference

UPDATE: Due to scheduling conflicts, we were unable to participate in this year’s conference.

New Brunswick, NJ (October 3^rd, 2022) -- Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 31^st Annual Global Healthcare Conference on Thursday, November 10^th, 2022 at the Terranea Resort in Rancho Palos Verdes, CA. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 12:50 p.m. (Eastern Time).

This audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48 hours after the live webcast.